CC
ONCT

Caxton Corporation’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Caxton Corporation’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-356
Closed -$763K – 31
2018
Q2 		$763K Buy
356
+3
+0.8% +$6.43K 0.27% 13
2018
Q1 		$877K Sell
353
-96
-21% -$239K 0.95% 11
2017
Q4 		$799K Hold
449
– – 0.97% 8
2017
Q3 		$531K Buy
+449
New +$531K 0.54% 10